2019
Pharmacologic and Radiation Therapies for Cancer-Induced Bone Loss.
Henderson SE, Dussik C, Brand J, Ibe IK, Lee FY. Pharmacologic and Radiation Therapies for Cancer-Induced Bone Loss. Instructional Course Lectures 2019, 68: 557-566. PMID: 32032067.Peer-Reviewed Original Research
2018
Immuno-oncologic Approach to Musculoskeletal Tumors
Ibe I, Sahlstrom A, Nguyen M, Lindskog D, Friedlaender G, Lee F. Immuno-oncologic Approach to Musculoskeletal Tumors. Techniques In Orthopaedics 2018, 33: 140-147. DOI: 10.1097/bto.0000000000000305.Peer-Reviewed Original ResearchImmune systemImmuno-oncologic therapiesSoft tissue sarcomasHost immune surveillanceActive immune responseTreatment of boneImmune therapyTumor burdenTissue sarcomasTreatment of cancerTreatment optionsMusculoskeletal tumorsComprehensive careImproved outcomesImmune surveillanceImmune responseOrthopedic oncologyMalignant cellsImmunotherapyCancer cellsPrecision medicineDistant sitesPatientsUnderlying mechanismTherapyMolecular Targeted Therapy Approach to Musculoskeletal Tumors
Ibe I, Haynes M, Koo A, Lindskog D, Friedlaender GE, Lee FY. Molecular Targeted Therapy Approach to Musculoskeletal Tumors. Techniques In Orthopaedics 2018, 33: 135-139. PMID: 36186916, PMCID: PMC9524233, DOI: 10.1097/bto.0000000000000298.Peer-Reviewed Original Research
2010
Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets
Onishi AC, Hincker AM, Lee FY. Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets. Sarcoma 2010, 2011: 381564. PMID: 21234363, PMCID: PMC3018623, DOI: 10.1155/2011/381564.Peer-Reviewed Original ResearchNature of chemotherapyNew molecular targetsDirected therapyPrimary malignancySurgical resectionRadiation regimensCurative treatmentMolecular mechanismsSuccessful treatmentTherapeutic targetChemotherapyChondrosarcomaMolecular targetsTumorsTherapy researchTreatmentCurrent hypothesesResectionRegimensPatientsMalignancyTherapyDiagnosis